News

September 29, 2010 – A prospective study found that an implantable cardiac monitor detected arrhythmias in patients who had suffered a heart attack.

Home September 29, 2010
Home
Technology

September 29, 2010 – An agreement was reached between AccessClosure and Benrikal Services for distributing vascular closure devices in the United States. AccessClosure will be the exclusive distributor for the Bengal Radial Compression Band, which helps close the radial artery after a cardiovascular procedure.

Home September 29, 2010
Home
News

September 28, 2010 – The Transcatheter Cardiovascular Therapeutics (TCT) 2010 symposium featured a live case broadcast of a physician implanting a new device to treat refractory angina.

Home September 28, 2010
Home
News

September 28, 2010 – A new multinational trial will examine the effectiveness of embolic protection mesh stents in STEMI (ST-elelvated myocardial infarction) patients. The MASTER trial will compare the MGuard coronary stent, made by InspireMD, with standard care. The MGuard stent is covered in a polymer mesh to prevent emboli from escaping when the stent is expanded.

Home September 28, 2010
Home
Technology

September 28, 2010 – A guiding catheter specifically designed for right radial access to maximize transradial interventional procedures is released in the United States. Terumo Interventional System’s Heartrail III Coronary Guiding Catheter is designed for use in the left or right coronary artery.

Home September 28, 2010
Home
News

September 28, 2010 - Software downloaded during a routine office visit cuts the risk of inappropriate shocks by 50 percent for patients with implantable cardioverter defibrillators (ICD), according to research reported in Circulation: Journal of the American Heart Association.

Home September 28, 2010
Home
News

September 28, 2010 – Three-year follow-up data from the HORIZONS-AMI trial presented at Transcatheter Cardiovascular Therapeutics (TCT) 2010 last week continues to show marked improvement of paclitaxel-eluting stents over bare metal stents in acute myocardial infarction (AMI).

Home September 28, 2010
Home
News

September 28, 2010 – A fully automatic, all-in-one ultrasound cleansing and disinfection system, the Mides Transesophageal (TEE)-Care, offers ease-of-use and safe handling. It was recently introduced in Europe.

Home September 28, 2010
Home
Technology

September 28, 2010 – Physicians can now determine whether a patient needs to have cardiac radionuclide imaging (RNI) by using a new smartphone app. The app, which is available for free on iPhone, BlackBerry and Android phones, gives physicians access to published criteria used to assess the need for RNI.

Home September 28, 2010
Home
News

September 27, 2010 – A post-market study investigating a new treatment for peripheral artery disease of the superficial femoral artery (SFA) has completed enrollment. The VIPER study, which is looking at the performance of the Gore Viabahn endoprosthesis with a heparin bioactive surface, enrolled 120 patients.

Home September 27, 2010
Home
Technology

September 27, 2010 — A new plug-in quickly and easily assesses clinically relevant parameters for abdominal aortic aneurysm (AAA) stent planning.

Home September 27, 2010
Home
News

September 27, 2010 – A premarket approval (PMA) application has been submitted for the Formula balloon-expandable stent to help treat patients suffering from renal artery stenosis. Cook Medical’s submission to the U.S. Food and Drug Administration (FDA) included data from the REFORM trial.

Home September 27, 2010
Home
Technology

September 27, 2010 - Treating varicose veins with a new access kit reduces the number of steps and reduces procedure time. The .018-inch nitinol long-access wire for the VenaCure EVLT system, by AngioDynamics, reduces the number of components involved.

Home September 27, 2010
Home
Technology

September 27, 2010 – Designed for productivity and versatility, the new GE Healthcare Innova 3100-IQ (Optima Edition) is a reliable, cost-effective, high-performance interventional combo lab for treating a wide variety of patients. It addresses diverse interventional cardiology and interventional radiology needs with one system. The system was unveiled at TCT 2010.

Home September 27, 2010
Home
News

September 24, 2010 - Trial data have established the safety of a reversible PAR-1 thrombin receptor antagonist in patients with acute coronary syndrome. Results from the LANCELOT ACS trial were presented at the Transcatheter Cardiovascular Therapeutics (TCT) 2010 meeting in Washington, D.C. The study looked at atopaxar, by Eisai Pharmaceuticals.

Home September 24, 2010
Home
Subscribe Now